Agents | Tests | Reference |
Tamoxifen, Toremifene, Fulvestrant, Letrozole, Anastrozole, Exemestane, Megestrol Acetate, Leuprolide, and Goserelin | ER | [35] - [43] |
PR | [35] - [41] [44] [45] | |
Fluorouracil, Capecitabine, and Pemetrexed | TS | [46] - [48] |
Paclitaxel, Docetaxel, and Nab-Paclitaxel | PGP | [49] [50] |
SPARC Monoclonal | [51] [52] | |
SPARC Polyclonal | [51] [52] | |
TUBB 3 | [53] - [56] | |
TLE3 | [57] | |
Gemcitabine | RRM1 | [58] |
Irinotecan | TOPO1 | [59] - [61] |
Everolimus and Temsirolimus | ER | [62] - [64] |
Her2/Neu | [61] [63] - [65] | |
PIK3CA | [66] - [68] | |
Imatinib | c-KIT | [69] [70] |
PDGFRA | [71] - [73] | |
Vandetanib | RET | [74] |
Doxorubicin, Liposomal-Doxorubicin, and Epirubicin | Her2/Neu | [75] [76] |
PGP | [77] [78] | |
TOP2A | [79] [80] | |
Erlotinib and Gefitibib | PTEN | [81] |
Trastuzumab, Pertuzumab, and Ado-trastuzumab Emtansine (T-DM1) | Her2/Neu | [62] [82] - [87] |
Lapatinib | Her2/Neu | [88] - [90] |
Temozolomide and dacarbazine | MGMT | [91] [92] |
Docetaxel and Paclitaxel | PGP | [49] [50] |
TLE3 | [57] | |
TUBB 3 | [53] - [56] |